Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Skeletal Muscle Bioenergetics in Critical Limb Ischemia and Diabetes
Victoria G. Rontoyanni
, Elizabeth Blears
, Omar Nunez Lopez
, John Ogunbileje
, Tatiana Moro
, Nisha Bhattarai
, Amanda C. Randolph
, Christopher S. Fry
, Grant T. Fankhauser
, Zulfiqar F. Cheema
,
Andrew J. Murton
, Elena Volpi
, Blake B. Rasmussen
, Craig Porter
Surgery
Internal Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Skeletal Muscle Bioenergetics in Critical Limb Ischemia and Diabetes'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Amputation
7%
Capacity Control
7%
Coupling Control
7%
Critical Limb Ischemia
100%
Diabetes
100%
Disease Development
7%
Disease Progression
7%
High-resolution Respirometry
7%
Limb muscles
7%
Lower Limb
7%
Major Risk Factors
7%
Metabolic Myopathy
7%
Mitochondrial Dysfunction
14%
Mitochondrial Respiratory Function
57%
Muscle Oxidative Capacity
7%
Myofiber
7%
Non-associated
7%
Patient-independent
7%
Peripheral Arterial Disease
14%
Permeabilized
7%
Respiration
21%
Revascularization
7%
Sex Effect
7%
Skeletal muscle
14%
Skeletal muscle Bioenergetics
100%
Type 2 Diabetes Mellitus (T2DM)
64%
Medicine and Dentistry
Amputation
7%
Arteriosclerosis Obliterans
14%
Critical Limb Ischemia
100%
Diabetes
100%
Disease Course
7%
Disease Exacerbation
7%
Lower Limb
7%
Maturity Onset Diabetes of the Young
64%
Mitochondrial Disorder
14%
Myopathy
7%
Respirometry
7%
Revascularization
7%
Skeletal Muscle
100%
Neuroscience
Diabetes Mellitus
64%
Ischemia
100%
Muscle Disorder
7%
Risk Factor
7%
Skeletal Muscle
100%
Biochemistry, Genetics and Molecular Biology
Bioenergy
100%
Mitochondrial Disorder
66%
Skeletal Muscle
100%
Pharmacology, Toxicology and Pharmaceutical Science
Critical Limb Ischemia
100%
Disease Course
7%
Disease Exacerbation
7%
Maturity Onset Diabetes of the Young
64%
Myopathy
7%
Peripheral Occlusive Artery Disease
14%